US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

30.71

-2.2900-6.94%

Volume:267.64K

Turnover:8.35M

Market Cap:2.13B

PE:-42.89

High:33.54

Open:32.70

Low:30.46

Close:33.00

52wk High:38.54

52wk Low:18.85

Shares:69.31M

Float Shares:12.94M

Volume Ratio:0.80

T/O Rate:2.07%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7160

EPS(LYR):-2.5873

ROE:-33.57%

ROA:-13.53%

PB:6.80

PE(LYR):-11.87

Loading ...

Overview Company News Filings

Alamar Biosciences Price Target Raised to $32.00/Share from $28.00 by Stifel

Top Midday Gainers

MT Newswires Live

Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum

Benzinga Earnings

Alamar Biosciences up over 18%, on Track for Record High Close and Record Percent Increase

BofA Adjusts Price Target on Alamar Biosciences to $31 From $30

MT Newswires Live

Alamar Biosciences price target raised to $32 from $28 at Stifel

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Alamar Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Alamar Biosciences Outlook FY Revenue $116 Mln-$120 Mln

THOMSON REUTERS

Alamar Biosciences reports Q2 EPS (22c), consensus (32c)

Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M

Alamar Biosciences Q2 2026 Net Loss Widens to $13.2 Million; Revenue Rises 82% to $29.4 Million

Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss

MT Newswires Live

Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate

Benzinga Earnings

Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures

THOMSON REUTERS

Alamar Biosciences Inc Expected to Post a Loss of 33 Cents a Share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish

Goldman Sachs-Backed Immunotherapy Pioneer Attovia (ATTO.US) Heads to Nasdaq: Targeting $212.5 Million in Top Funding, Adding Fuel to Biotech IPO Boom

Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ALMR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences","latestPrice":30.71,"timestamp":1787947200000,"preClose":33,"halted":0,"volume":267641,"delay":0,"changeRate":-0.06939393939393937,"floatShares":12937500,"shares":69311200,"eps":-0.716,"marketStatus":"Pre-Mkt","change":-2.29,"latestTime":"08-31 04:03:43 EDT","open":32.7,"high":33.54,"low":30.455,"amount":8348250.845693001,"amplitude":0.093485,"askPrice":48.7,"askSize":100,"bidPrice":29.23,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.716,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788183000000},"marketStatusCode":1,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":30.71,"postHourTrading":{"tag":"盘后","latestPrice":30.71,"preClose":30.71,"latestTime":"19:30 EDT","volume":2754,"amount":84575.61,"timestamp":1787959806564,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7980602591808754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","floatShares":12937500,"roa":"-13.53%","roe":"-33.57%","lyrEps":-2.587299,"volumeRatio":0.7980602591808754,"shares":69311200,"dividePrice":0,"high":33.54,"amplitude":0.093485,"preClose":33,"low":30.455,"week52Low":18.845,"pbRate":"6.80","psRate":"21.20","week52High":38.54,"institutionHeld":0,"latestPrice":30.71,"committee":-0.980198,"eps":-0.716,"divideRate":0,"volume":267641,"delay":0,"ttmEps":-0.716,"open":32.7,"prevYearClose":17,"prevWeekClose":34.24,"prevMonthClose":25.36,"prevQuarterClose":27.09,"fiveDayClose":34.24,"twentyDayClose":25.36,"sixtyDayClose":20.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"ALMR","fiscalQuarterEnding":"2026/06","expectedEps":-0.36,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1779249600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMR","date":"2026-08-28","current":-42.891061,"percent":0.258824,"low":-61.051551,"twenty":-47.844552,"median":-41.354,"eighty":-34.253131,"high":-30.427746,"avg":-42.128864,"sd":7.961206,"marketCap":2289961278},"quantilePoints":[{"date":"2026-05-01","current":-57.277289,"twenty":-59.990183,"median":-57.277289,"eighty":-56.655108,"marketCap":1707951482},{"date":"2026-05-08","current":-54.120633,"twenty":-59.175857,"median":-56.408065,"eighty":-54.495772,"marketCap":1613823165},{"date":"2026-05-15","current":-35.878919,"twenty":-57.629553,"median":-54.669617,"eighty":-53.99338,"marketCap":1560194796},{"date":"2026-05-22","current":-35.066025,"twenty":-56.9113,"median":-54.440874,"eighty":-34.919385,"marketCap":1524846092},{"date":"2026-05-29","current":-31.495666,"twenty":-56.325717,"median":-53.802501,"eighty":-32.467951,"marketCap":1369589035},{"date":"2026-06-05","current":-34.253131,"twenty":-55.282649,"median":-35.878919,"eighty":-32.646469,"marketCap":1489497387},{"date":"2026-06-12","current":-35.368868,"twenty":-54.724515,"median":-34.699426,"eighty":-32.401007,"marketCap":1538015217},{"date":"2026-06-18","current":-32.196986,"twenty":-54.651317,"median":-34.308917,"eighty":-32.158732,"marketCap":1400085957},{"date":"2026-06-26","current":-42.828368,"twenty":-54.587269,"median":-35.066025,"eighty":-32.350002,"marketCap":1862391567},{"date":"2026-07-02","current":-41.648874,"twenty":-54.495772,"median":-35.368868,"eighty":-32.60184,"marketCap":1811101290},{"date":"2026-07-10","current":-42.206743,"twenty":-54.303628,"median":-36.436788,"eighty":-32.691099,"marketCap":1835360205},{"date":"2026-07-17","current":-39.76806,"twenty":-53.99338,"median":-39.098618,"eighty":-32.700662,"marketCap":1729314090},{"date":"2026-07-24","current":-41.266336,"twenty":-53.295956,"median":-39.903543,"eighty":-32.786733,"marketCap":1794466605},{"date":"2026-07-31","current":-39.959329,"twenty":-52.542305,"median":-39.576791,"eighty":-32.978002,"marketCap":1737631433},{"date":"2026-08-07","current":-44.788877,"twenty":-45.298929,"median":-40.039025,"eighty":-33.153333,"marketCap":1947644326},{"date":"2026-08-14","current":-46.000078,"twenty":-46.279543,"median":-40.206385,"eighty":-33.248967,"marketCap":2284409856},{"date":"2026-08-21","current":-48.403484,"twenty":-48.403484,"median":-40.899736,"eighty":-33.37648,"marketCap":2403765414},{"date":"2026-08-28","current":-46.111864,"twenty":-47.844552,"median":-41.354,"eighty":-34.253131,"marketCap":2289961278}],"updateTime":1788136851119},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658917839","title":"Alamar Biosciences Price Target Raised to $32.00/Share from $28.00 by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658917839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:51","pubTimestamp":1786470660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMR/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658122669","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658122669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658122669?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:33","pubTimestamp":1786469637,"startTime":"0","endTime":"0","summary":"Quantum  swung to non-GAAP adjusted net income in fiscal Q1, while revenue exceeded the company's own guidance range, it said late Monday.Shares soared nearly 61% amid a surge in intraday trading volume to over 11.8 million from a daily average of about 1.14 million.NIQ Global Intelligence  reported Q2 adjusted earnings late Monday, swinging from a loss a year earlier. Revenue grew faster than the market had forecast.Shares surged 41% as intraday trading volume jumped to over 6.01 million from a daily average of roughly 1.57 million.Alamar Biosciences  reported a narrower Q2 net loss and sales above consensus late Monday.Shares advanced 34%, with intraday trading volume rising to more than 667,000 from the stock's daily average of about 286,000.Price: 18.65, Change: +6.87, Percent Change: +58.32","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NIQ","BK4121","BK4170","ALMR","QMCO","BK4602","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912131","title":"Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912131","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912131?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:25","pubTimestamp":1786469146,"startTime":"0","endTime":"0","summary":"Alamar Biosciences expands its Alzheimer’s data partnership, adds 86,000 samples and reports Q2 sales growth of 82% year-over-year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61120052/alamar-biosciences-stock-soars-ceo-says-company-is-well-positioned-to-sustain-upcoming-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODDS","ODDZ","BK4150","BETZ","BK4121","RSI","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919998","title":"Alamar Biosciences up over 18%, on Track for Record High Close and Record Percent Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919998","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919998?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:42","pubTimestamp":1786459320,"startTime":"0","endTime":"0","summary":"Alamar Biosciences, Inc.  is currently at $33.24, up $5.26 or 18.77%--Would be new all-time closing high --Would be largest percent increase on record --Currently up seven of the past nine days--Up 31.09% month-to-date--Would be a new 52-week closing high--Up 74.15% from its 52-week closing low of $19.09 on May 26, 2026--Traded as high as $33.59; new all-time intraday high --Up 20.01% at today's intraday high; largest intraday percent increase on record All data as of 10:40:08 AM ETSource: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990131","title":"BofA Adjusts Price Target on Alamar Biosciences to $31 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990131","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990131?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:13","pubTimestamp":1786450433,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) has an average rating of buy and mean price target of $33.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997656","title":"Alamar Biosciences price target raised to $32 from $28 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997656?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:42","pubTimestamp":1786448552,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Alamar Biosciences (ALMR) to $32 from $28 and keeps a Buy rating on the shares after the company posted a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998279","title":"U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658998279?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:10","pubTimestamp":1786435846,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna TherapeuticsAug 11 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N4480HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKD","ALMR","SECZ","AAON","IYH","ABBV","DRTS","AAOI","TGT","BOEU","TPYP","IGE","ITA","CEVA","ORBX","ASTS","CHMI","AGL","BKV","APP","BA","CRC","ASPN","RXL","IEO","AMAT","LNG","AXSM","FTXH","ASTH","BBIO","CLS","ACH","CODI","MO","OILT","AFL","BBY","ALL","CNC","COGT","CON","ANF","COP","BWMN","ACVA","AFG","CLBK","COR","CENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952467","title":"Alamar Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952467?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:38","pubTimestamp":1786397923,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Inc reports results for the quarter ended June 30 - Earnings SummaryAlamar Biosciences IncALMR.OQreported a quarterly adjusted loss of 22 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44723J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954341","title":"Alamar Biosciences Outlook FY Revenue $116 Mln-$120 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954341?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:53","pubTimestamp":1786395213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXD7W9SP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658039951","title":"Alamar Biosciences reports Q2 EPS (22c), consensus (32c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658039951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658039951?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394141,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $29.4M, consensus $25.94M. “We delivered a strong second quarter with consumable revenue growing nearly 150% year-over-year,” sa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951055","title":"Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951055?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394137,"startTime":"0","endTime":"0","summary":"16:32 EDT Alamar Biosciences (ALMR) sees FY26 revenue $116M-$120M, consensus $113.22M Published first on TheFly – the ultimate source for real-time...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658495168","title":"Alamar Biosciences Q2 2026 Net Loss Widens to $13.2 Million; Revenue Rises 82% to $29.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658495168","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658495168?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:30","pubTimestamp":1786393805,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Q2 2026 net loss widens to $13.2 million; revenue rises 82% to $29.4 millionAlamar Biosciences posted Q2 revenue of $29.4 million, up 82% year over year.Net loss widened to $13.2 mi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL7Yf7FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658597819","title":"Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658597819","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658597819?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:18","pubTimestamp":1786393122,"startTime":"0","endTime":"0","summary":"Earnings Flash (ALMR) Alamar Biosciences Posts Q2 Loss Per Share $0.22, vs. FactSet Est of $0.31 Loss","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658295919","title":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658295919","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658295919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392790,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/ALMR","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alamar Biosciences Q2 EPS $(0.22) Beats $(0.33) Estimate, Sales $29.427M Beat $25.940M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695647","title":"Alamar Biosciences Expands Global Partnership with Alzheimer’s Disease Data Initiative and Gates Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695647","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658695647?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:03","pubTimestamp":1786392180,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4Z3MS6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657215316","title":"Alamar Biosciences Inc Expected to Post a Loss of 33 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657215316","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657215316?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:56","pubTimestamp":1786139767,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Inc <ALMR.OQ> expected to post a loss of33cents a share - Earnings PreviewAlamar Biosciences IncALMR.OQALMR.Ois expected to  report resultson August 10 for the period ending June 30 2026The Fremont California-based  company is expected to report revenue of $25.94 million, according to the mean estimate from 5 analysts, based on LSEG data.LSEG's mean analyst estimate for Alamar Biosciences Inc is for a loss of 33 cents per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 4 \"strong buy\" or \"buy,\" 1 \"hold\" and no \"sell\" or \"strong sell.\"The average consensus recommendation for the advanced medical equipment & technology peer group is also \"Buy\".Wall Street's median 12-month price target for Alamar Biosciences Inc is $32.00, about 13.9% above its last closing price of $28.10This summary was machine generated August 7 at 21:56 GMT.  All figures in US dollars unless otherwise stated.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657614462","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2657614462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657614462?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:00","pubTimestamp":1786096800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Company                                   Symbol     Quarter  Mean  Report Time. ACM Research Inc. Class A                       2Q       .42       BMO. Algonquin Power & Utilities Corp.                2Q       .03   6:30 AM. Alpha Metallurgical Resources Inc.               2Q      (.43)  7:30 AM. Construction Partners Inc. Class A              3Q      1.01       BMO. Kimbell Royalty Partners LP                      2Q       .23   7:00 AM. Park Hotels & Resorts Inc.                        2Q       .25       AMC. Plains All American Pipeline L.P.                2Q       .38   7:30 AM. Plains GP Hldgs LP Class A                      2Q       .46   7:30 AM. Rapid Micro BioSyss Inc. Class A                2Q      (.24)      BMO. Spectrum Brands Hldgs Inc.                       3Q      1.46   6:30 AM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEVA","BZH","BTDR","ELTX","ACMR","ANIP","UA","B","CBLL","ACVA","DCBO","ATMU","AXSM","EMBC","ACM","BKD","CNTY","ARQ","ACHR","BODI","BWMN","CIB","DCH","AQN","CGC","ELVA","DH","CTEV","CODI","CAMT","ALC","ASTS","AMR","CECO","DCGO","CNDT","AMTM","ANAB","BBIO","CLMT","CRC","CCAP","DMAC","ACH","ALMR","AIOT","EMA","APEI","AAON","BCSF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178681101","title":"Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1178681101","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178681101?lang=en_us&edition=fundamental","pubTime":"2026-08-03 10:30","pubTimestamp":1785724253,"startTime":"0","endTime":"0","summary":"Abstract Alamar Biosciences will report second-quarter 2026 financial results on August 10, 2026 Post-Mkt, and investors are focused on top-line durability, margin trajectory, and whether losses...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Alamar Biosciences Q2 revenue is expected to decrease by 0.37%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199227711","title":"Goldman Sachs-Backed Immunotherapy Pioneer Attovia (ATTO.US) Heads to Nasdaq: Targeting $212.5 Million in Top Funding, Adding Fuel to Biotech IPO Boom","url":"https://stock-news.laohu8.com/highlight/detail?id=1199227711","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199227711?lang=en_us&edition=fundamental","pubTime":"2026-07-30 12:00","pubTimestamp":1785384038,"startTime":"0","endTime":"0","summary":"With biotech IPOs delivering an average 55% return, outpacing the AI sector and emerging as the top performer in 2026 U.S. stock markets, another clinical-stage biopharmaceutical company is joining...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","ATTO","LU2237443465.HKD","LU2237443895.HKD","BK4226","BK4533","LU1868836757.USD","LU0048573561.USD","LU0345770993.USD","LU2237443549.SGD","LU1868836591.USD","LU0106831901.USD","LU0742534661.SGD","LU2750360641.GBP","LU2265009873.SGD","LU1894683348.USD","LU2237438978.USD","LU2471134796.USD","LU2750360997.AUD","LU0942090050.USD","LU0061475181.USD","GS","IE0004086264.USD","IE0004091025.USD","LU0868494708.USD","GSX","IE0002270589.USD","LU2471134879.HKD","LU1804176565.USD","IE0034235188.USD","LU2237443622.USD","LU2471134523.USD","LU2237443382.USD","BK4552","BK4516","BK4504","LU1868836914.USD","LU1894683264.USD","BK4121","BK4588","LU2471134952.CNY","LU0251142724.SGD","BK4585","LU0096364046.USD","LU2237443978.SGD","LU0251131958.USD","LU1868837136.USD","LU1668664300.SGD","IE00BFXG1179.USD","LU1791807156.HKD","LU1868837300.USD","BK4143","LU0868494617.USD","BK4127","ALMR","IE00B19Z3581.USD","LU0345770308.USD","IE00B19Z3B42.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655368908","title":"Alamar Biosciences Launches NULISAseq™ Immune 340 Panel for Comprehensive Profiling of the Immune Proteome","url":"https://stock-news.laohu8.com/highlight/detail?id=2655368908","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655368908?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:12","pubTimestamp":1785269520,"startTime":"0","endTime":"0","summary":"Expanded panel advances the understanding of immune system across translational and clinical research in cancer, cardiovascular and metabolic diseases, autoimmune diseases and aging Highly sensitive m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/28/3334730/0/en/Alamar-Biosciences-Launches-NULISAseq-Immune-340-Panel-for-Comprehensive-Profiling-of-the-Immune-Proteome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}